Owens & Minor (NYSE: OMI) recently received a number of ratings updates from brokerages and research firms:
- 11/5/2024 – Owens & Minor had its price target lowered by analysts at Robert W. Baird from $19.00 to $14.00. They now have a “neutral” rating on the stock.
- 11/5/2024 – Owens & Minor had its price target lowered by analysts at Barclays PLC from $18.00 to $14.00. They now have an “equal weight” rating on the stock.
- 11/5/2024 – Owens & Minor had its price target lowered by analysts at UBS Group AG from $28.00 to $25.00. They now have a “buy” rating on the stock.
- 11/5/2024 – Owens & Minor had its price target lowered by analysts at Citigroup Inc. from $21.00 to $18.50. They now have a “buy” rating on the stock.
Owens & Minor Price Performance
Shares of OMI opened at $12.35 on Monday. The company has a 50 day moving average of $13.75 and a two-hundred day moving average of $15.16. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor, Inc. has a twelve month low of $11.42 and a twelve month high of $28.35. The company has a market cap of $952.31 million, a price-to-earnings ratio of -19.00, a price-to-earnings-growth ratio of 0.43 and a beta of 0.41.
Owens & Minor (NYSE:OMI – Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The firm had revenue of $2.72 billion during the quarter, compared to analysts’ expectations of $2.68 billion. During the same quarter last year, the firm earned $0.44 EPS. The business’s quarterly revenue was up 5.0% on a year-over-year basis. As a group, analysts predict that Owens & Minor, Inc. will post 1.49 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Further Reading
- Five stocks we like better than Owens & Minor
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Forces Shaping a Bullish 2025 Outlook
- ESG Stocks, What Investors Should Know
- Should Investors Chase Tech Gains Into Year-End?
- Options Trading – Understanding Strike Price
- 2 Solar Stocks to Watch as Election Sparks Uncertainty
Receive News & Ratings for Owens & Minor Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc and related companies with MarketBeat.com's FREE daily email newsletter.